MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.hjc.2024.10.004

Медицинская библиотека · Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese · 2024

Comparison of continuous flow centrifugal left ventricular assist devices as a bridge to transplant strategy in a low organ donation environment: single center experience.

Bonios Michael, Miliopoulos Dimitris, Gkouziouta Angeliki, Kogerakis Nektarios, Fragkoulis Sokratis, Armenis Iakovos, Zarkalis Dimitrios, Ieromonachos Konstantinos, Koliopoulou Antigoni, Leontiadis Evangelos, Georgiadou Panagiota, Vartela Vasiliki, Tsiapras Dimitrios, Sfirakis Petros, Kapelios Christos, Dimopoulos Stavros, Kaklamanis Loukas, Ntegiannis Dimitrios, Antoniou Theofani, Chamogeorgakis Themistokles, Adamopoulos Stamatis

СтатьяСравнительное исследованиеПеревод в очереди

Аннотация

OBJECTIVE

In patients with advanced heart failure, heart transplantation is currently the most effective treatment. However, in a low-organ donation environment, it is usually necessary to proceed in long-term mechanical circulatory support through left ventricular assist device (LVAD) implantation as bridge-to-transplantation.

METHODS

The study included all patients with advanced heart failure who underwent continuous flow LVAD implantation as a bridge to transplant strategy in our center (n = 68). Following LVAD implantation and for the period that patients were on LVAD support, pump thrombosis, strokes, gastrointestinal bleeding, and right heart failure occurrence rates were recorded. Outcomes were compared between patients implanted with HeartMate 3 (HM3) and HeartWare LVADs, as well as between patients who did reach heart transplantation (HTx group) and those who did not (noHTx group).

RESULTS

A total of 35 out of 68 patients underwent heart transplantation at a mean time of 691 ± 457 days; 41 received a HeartWare and 27 a HM3 device. HM3 patients had significantly better survival (p = 0.010) and lower complication rates (p = 0.025). In addition, the noHTx group had significantly higher complication rates compared with the HTx group (p = 0.00041). The 5-year estimated Kaplan-Meier survival rate following heart transplantation was 77%.

CONCLUSION

Patients with advanced heart failure gain substantial benefit from LVADs awaiting heart transplantation. In a low organ donation environment, the need for reliable LVADs can further improve the outcomes through the reduction of complications provided by current devices.

Для цитирования: Bonios Michael, Miliopoulos Dimitris, Gkouziouta Angeliki, Kogerakis Nektarios, Fragkoulis Sokratis, Armenis Iakovos, Zarkalis Dimitrios, Ieromonachos Konstantinos, Koliopoulou Antigoni, Leontiadis Evangelos, Georgiadou Panagiota, Vartela Vasiliki, Tsiapras Dimitrios, Sfirakis Petros, Kapelios Christos, Dimopoulos Stavros, Kaklamanis Loukas, Ntegiannis Dimitrios, Antoniou Theofani, Chamogeorgakis Themistokles, Adamopoulos Stamatis. Comparison of continuous flow centrifugal left ventricular assist devices as a bridge to transplant strategy in a low organ donation environment: single center experience.. Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese. 2024. DOI: 10.1016/j.hjc.2024.10.004.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.